Foot-and-mouth disease virus non-structural protein 3A inhibits the interferon-β signaling pathway

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Li, Dan ^a   Lei, Caoqi ^b   Xu, Zhisheng ^b   Yang, Fan ^a   Liu, Huanan ^a   Zhu, Zixiang ^b   Li, Shu ^a   Liu, Xiangtao ^a   Shu, Hongbing ^b   Zheng, Haixue ^a  

^a National Foot and Mouth Disease Reference Laboratory   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DDX58 PROTEIN, HUMAN; IFIH1 PROTEIN, HUMAN; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; RETINOIC ACID INDUCIBLE PROTEIN I; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VIRAL PROTEIN; VISA PROTEIN, HUMAN;

ANIMAL; FOOT AND MOUTH DISEASE VIRUS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHYSIOLOGY; PIG; PROTEIN ANALYSIS; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; DEAD BOX PROTEIN 58; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-BETA; INTERFERON-INDUCED HELICASE, IFIH1; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; SIGNAL TRANSDUCTION; SUS SCROFA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84958999529     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21888     Document Type: Article

References (50)

1. Knowles, N. J., Samuel, A. R. Molecular epidemiology of foot-and-mouth disease virus. Virus Res 91, 65-80 (2003).
2. Domingo, E. et al. Evolution of foot-and-mouth disease virus. Virus Res 91, 47-63 (2003).
3. Belsham, G. J. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Bio 60, 241-260 (1993).
4. Akira, S., Uematsu, S., Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
5. Janeway, C. A., Jr., Medzhitov, R. Innate immune recognition. Annu Rev Immunol 20, 197-216 (2002).
6. Stetson, D. B., Medzhitov, R. Type I interferons in host defense. Immunity 25, 373-381 (2006).
7. Goubau, D., Deddouche, S., Reis e Sousa, C. Cytosolic sensing of viruses. Immunity 38, 855-869 (2013).
8. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5, 730-737 (2004).
9. Yoneyama, M., Fujita, T. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29, 178-181 (2008).
10. Kang, D. C. et al. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. PNAS 99, 637-642 (2002).
11. Yoneyama, M. et al. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J 17, 1087-1095 (1998).
12. Sato, M. et al. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. Febs Lett 425, 112-116 (1998).
13. Sellers, R. F. et al. Some factors affecting interferon production by foot-and-mouth disease virus in bovine tissue culture. Arch Gesamte Virusforsch 23, 1-11 (1968).
14. Nfon, C. K. et al. Interferon-alpha production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus. Viral Immunol 21, 68-77 (2008).
15. Chinsangaram, J. et al. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol 73, 9891-9898 (1999).
16. de Los Santos, T. et al. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol 80, 1906-1914 (2006).
17. Du, Y. et al. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation. J Virol 88, 4908-4920 (2014).
18. de Los Santos, T. et al. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol 81, 12803-12815 (2007).
19. Wang, D. et al. 2010. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem Biophy Res Co 399, 72-78 (2010).
20. Wang, D. et al. Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-lambda1 pathway. Mol Immunol 49, 407-412 (2011).
21. Wang, D. et al. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J Virol 86, 9311-9322 (2012).
22. Li, X. et al. Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells. Vet Microbiol 166, 35-46 (2013).
23. Aguirre, S. et al. DENV Inhibits Type I IFN Production in Infected Cells by Cleaving Human STING. Plos Pathog 8(10), e1002934 (2012).
24. Medina, M., Domingo, E., Brangwyn, J. K., Belsham, G. J. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 194, 355-359 (1993).
25. Mibayashi, M. et al. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81, 514-524 (2007).
26. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5, 730-737 (2004).
27. Andrejeva, J. et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. PNAS 101, 17264-17269 (2004).
28. Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-1172 (2005).
29. Lin, R. et al. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 80, 6072-6083 (2006).
30. Loo, Y. M. et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. PNAS 103, 6001-6006 (2006).
31. Wei, C. W. et al. The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein. J Immunol 185, 1158-1168 (2010).
32. Kumar, M. et al. Hepatitis B Virus Regulatory HBx Protein Binds to Adaptor Protein IPS-1 and Inhibits the Activation of Beta Interferon. J Virol 85, 987-995 (2011).
33. Yang, Y. et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. PNAS 104, 7253-7258 (2007).
34. Mukherjee, A. et al. The Coxsackievirus B 3C(pro) Protease Cleaves MAVS and TRIF to Attenuate Host Type I Interferon and Apoptotic Signaling. Plos Pathog 7(3), e1001311 (2011).
35. Wang, B. et al. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. Plos Pathog 9, e1003231 (2013).
36. Valarcher, J. F. et al. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol 77, 8426-8439 (2003).
37. Keller, B. C. et al. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol 80, 9424-9434 (2006).
38. Graef, K. M. et al. The PB2 Subunit of the Influenza Virus RNA Polymerase Affects Virulence by Interacting with the Mitochondrial Antiviral Signaling Protein and Inhibiting Expression of Beta Interferon. J Virol 84, 8433-8445 (2010).
39. Knowles, N. J. et al. Emergence in Asia of foot-and-mouth disease viruses with altered host range: characterization of alterations in the 3A protein. J Virol 75, 1551-1556 (2001).
40. Gladue, D. P. et al. et al. Interaction of foot-and-mouth disease virus nonstructural protein 3A with host protein DCTN3 is important for viral virulence in cattle. J Virol 88, 2737-2747 (2014).
41. Gonzalez-Magaldi, M., Martin-Acebes, M. A., Kremer, L., Sobrino, F. Membrane topology and cellular dynamics of foot-andmouth disease virus 3A protein. Plos one 9, e106685 (2014).
42. Giraudo, A. T. et al. Identification of a nucleotide deletion in parts of polypeptide 3A in two independent attenuated aphthovirus strains. Virology 177, 780-783 (1990).
43. Pacheco, J. M. et al. A partial deletion in non-structural protein 3A can attenuate foot-and-mouth disease virus in cattle. Virology 446, 260-267 (2013).
44. Diao, F. et al. Negative regulation of MDA5-but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. PNAS 104, 11706-11711 (2007).
45. Lei, C. Q. et al. Glycogen synthase kinase 3beta regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 33, 878-889 (2010).
46. Xu, L. G. et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19, 727-740 (2005).
47. Huang, J. et al. SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3-and virus-triggered IRF-3 activation pathways. EMBO J 24, 4018-4028 (2005).
48. Wang, C. et al. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nat Immunol 10, 744-752 (2009).
49. Zhong, B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538-550 (2008).
50. Moniwa, M. et al. Performance of a foot-and-mouth disease virus reverse transcription-polymerase chain reaction with amplification controls between three real-time instruments. J Vet Diagn Invest 19, 9-20 (2007).